Home
>
US Stocks
>
Neuronetics Inc
Neuronetics Inc
STIM

Neuronetics Inc

$5.0427.9%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
4.87
Today Low/High
4.87 / 5.09
52 Week Low/High
$3.96 / $22.43
Market Cap
$206.07M

Company Details

Neuronetics, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its commercial product, the NeuroStar® Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The system is cleared by the United States Food and Drug Administration, or FDA, for the treatment of major depressive disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. Visit NeuroStar.com for safety information and indications for use. NeuroStar is also available in other parts of the world, including Japan, where it is listed under Japan's national health insurance.
Organisation
Neuronetics Inc
Headquaters
Malvern, Pennsylvania, US
Employees
126
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Neuronetics Inc share price today

Can Indians buy Neuronetics Inc shares?

How can I buy Neuronetics Inc shares from India?

Can Fractional shares of Neuronetics Inc be purchased?

What are the documents required to start investing in Neuronetics Inc stocks?

We are a SEBI registered investement advisor